Literature DB >> 1711209

Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients.

L Mosthaf1, B Vogt, H U Häring, A Ullrich.   

Abstract

The human insulin receptor exists in two isoforms, HIR-A and HIR-B, which are generated by alternative splicing of a primary gene transcript and differ by a 12-amino acid insertion sequence in the alpha-subunit. The two receptor isoforms bind insulin with different affinities and are differentially expressed in human tissues. We report here a tissue-specific alteration of the insulin receptor RNA splice pattern in non-insulin-dependent diabetes mellitus (NIDDM) patients. Whereas skeletal muscle of healthy individuals contains exclusively high-affinity HIR-A-encoding RNA, we consistently find low-affinity HIR-B RNA expression in NIDDM muscle tissue at levels similar to HIR-A.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711209      PMCID: PMC51739          DOI: 10.1073/pnas.88.11.4728

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

Review 2.  The insulin receptor and the molecular mechanism of insulin action.

Authors:  C R Kahn; M F White
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

Review 3.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Alternative splicing of human insulin receptor messenger RNA.

Authors:  S Seino; G I Bell
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

5.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.

Authors:  G R Freidenberg; R R Henry; H H Klein; D R Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing.

Authors:  Y Yoshimasa; S Seino; J Whittaker; T Kakehi; A Kosaki; H Kuzuya; H Imura; G I Bell; D F Steiner
Journal:  Science       Date:  1988-05-06       Impact factor: 47.728

7.  Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM.

Authors:  D E Moller; A Yokota; J S Flier
Journal:  Diabetes       Date:  1989-11       Impact factor: 9.461

8.  Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance.

Authors:  T Kadowaki; C L Bevins; A Cama; K Ojamaa; B Marcus-Samuels; H Kadowaki; L Beitz; C McKeon; S I Taylor
Journal:  Science       Date:  1988-05-06       Impact factor: 47.728

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes.

Authors:  D Accili; C Frapier; L Mosthaf; C McKeon; S C Elbein; M A Permutt; E Ramos; E Lander; A Ullrich; S I Taylor
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  32 in total

Review 1.  The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance.

Authors:  H U Häring
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

2.  Obesity, Diabetes and Cancer: A Mechanistic Perspective.

Authors:  V Cifarelli; S D Hursting
Journal:  Int J Diabetol Vasc Dis Res       Date:  2015-09-28

3.  Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein.

Authors:  G Sesti; A N Tullio; R D'Alfonso; M L Napolitano; M A Marini; P Borboni; R Longhi; L Albonici; A Fusco; A M Aglianò
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

4.  Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes.

Authors:  L Mosthaf; J Eriksson; H U Häring; L Groop; E Widen; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  Regulation of human insulin receptor RNA splicing in vivo.

Authors:  S Norgren; J Zierath; A Wedell; H Wallberg-Henriksson; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.

Authors:  Supriya Sen; Indrani Talukdar; Nicholas J G Webster
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

7.  Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension.

Authors:  H Valensise; Y Y Liu; M Federici; D Lauro; D Dell'anna; C Romanini; G Sesti
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

8.  Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.

Authors:  Z Huang; N L Bodkin; H K Ortmeyer; B C Hansen; A R Shuldiner
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type 2 (non-insulin-dependent) diabetic subjects.

Authors:  M Kellerer; G Sesti; E Seffer; B Obermaier-Kusser; D E Pongratz; L Mosthaf; H U Häring
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

Review 10.  Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle.

Authors:  H U Häring; H Mehnert
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.